Akari Therapeutics (AKTX) Cash from Investing Activities (2014 - 2018)
Akari Therapeutics recorded quarterly Cash from Investing Activities of $379075.0 in Q4 2018, down 96.21% quarter-over-quarter from $10.0 million in Q2 2017.
Akari Therapeutics' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $379075.0 for Q4 2018.
- In Q4 2018, Cash from Investing Activities changed N/A year-over-year to $379075.0; the TTM figure through Dec 2018 stood at $379075.0 (down 96.2% YoY), while the FY2024 annual figure was $382000.0, changed N/A from the prior year.
- Cash from Investing Activities came in at $379075.0 for Q4 2018 at Akari Therapeutics, down from $10.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $35.1 million in Q4 2016 to a low of -$46.1 million in Q2 2016.
- A 5-year average of $153574.5 and a median of $142000.0 in 2014 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 186918.06% in 2016 and fell as far as 27.76% in 2016.
- Akari Therapeutics' Cash from Investing Activities stood at $142000.0 in 2014, then tumbled by 113.22% to -$18779.0 in 2015, then soared by 186918.06% to $35.1 million in 2016, then plunged by 71.52% to $10.0 million in 2017, then slumped by 96.21% to $379075.0 in 2018.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $379075.0, $10.0 million, and -$5620.0 for Q4 2018, Q2 2017, and Q1 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 172.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 379,075.00 |
| Dec 31, 2018 | 379,075.00 |
| Jun 30, 2017 | 9.99 Mn |
| Jun 30, 2017 | 9.99 Mn |
| Mar 31, 2017 | -5,620.00 |
| Mar 31, 2017 | -5,620.00 |
| Dec 31, 2016 | 35.08 Mn |
| Dec 31, 2016 | 35.08 Mn |
| Sep 30, 2016 | 1.02 Mn |
| Sep 30, 2016 | 1.02 Mn |
| Jun 30, 2016 | -46.13 Mn |
| Jun 30, 2016 | -46.13 Mn |
| Mar 31, 2016 | -42,083.00 |
| Mar 31, 2016 | -42,083.00 |
| Dec 31, 2015 | -18,779.00 |
| Dec 31, 2015 | -18,779.00 |
| Sep 30, 2015 | 1.41 Mn |
| Sep 30, 2015 | 1.41 Mn |
| Sep 30, 2014 | 142,000.00 |
| Sep 30, 2014 | 142,000.00 |
| Jun 30, 2014 | -142,000.00 |
| Jun 30, 2014 | -142,000.00 |